Literature DB >> 31866002

Structure of an Unfolding Intermediate of an RRM Domain of ETR-3 Reveals Its Native-like Fold.

Harshesh Bhatt1, Akshay Kumar Ganguly1, Sonam Sharma1, Gajraj Singh Kushwaha1, Mohammad Firoz Khan2, Sobhan Sen2, Neel Sarovar Bhavesh3.   

Abstract

Prevalence of one or more partially folded intermediates during protein unfolding with different secondary and ternary conformations has been identified as an integral character of protein unfolding. These transition-state species need to be characterized structurally for elucidation of their folding pathways. We have determined the three-dimensional structure of an intermediate state with increased conformational space sampling under urea-denaturing condition. The protein unfolds completely at 10 M urea but retains residual secondary structural propensities with restricted motion. Here, we describe the native state, observable intermediate state, and unfolded state for ETR-3 RRM-3, which has canonical RRM fold. These observations can shed more light on unfolding events for RRM-containing proteins.
Copyright © 2019 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31866002      PMCID: PMC6976808          DOI: 10.1016/j.bpj.2019.11.3392

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  64 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

Review 2.  New tools provide new insights in NMR studies of protein dynamics.

Authors:  Anthony Mittermaier; Lewis E Kay
Journal:  Science       Date:  2006-04-14       Impact factor: 47.728

3.  Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Lionel M Igaz; Linda K Kwong; Yan Xu; Adam C Truax; Kunihiro Uryu; Manuela Neumann; Christopher M Clark; Lauren B Elman; Bruce L Miller; Murray Grossman; Leo F McCluskey; John Q Trojanowski; Virginia M-Y Lee
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

Review 4.  Kinetic studies of protein folding using NMR spectroscopy.

Authors:  C M Dobson; P J Hore
Journal:  Nat Struct Biol       Date:  1998-07

5.  A single cardiac troponin T gene generates embryonic and adult isoforms via developmentally regulated alternate splicing.

Authors:  T A Cooper; C P Ordahl
Journal:  J Biol Chem       Date:  1985-09-15       Impact factor: 5.157

6.  Residue-level NMR view of the urea-driven equilibrium folding transition of SUMO-1 (1-97): native preferences do not increase monotonously.

Authors:  Ashutosh Kumar; Sudha Srivastava; Ram Kumar Mishra; Rohit Mittal; Ramakrishna V Hosur
Journal:  J Mol Biol       Date:  2006-06-19       Impact factor: 5.469

Review 7.  Specific intermediates in the folding reactions of small proteins and the mechanism of protein folding.

Authors:  P S Kim; R L Baldwin
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

Review 8.  Intermediates: ubiquitous species on folding energy landscapes?

Authors:  David J Brockwell; Sheena E Radford
Journal:  Curr Opin Struct Biol       Date:  2007-01-18       Impact factor: 6.809

9.  Folding of the RNA recognition motif (RRM) domains of the amyotrophic lateral sclerosis (ALS)-linked protein TDP-43 reveals an intermediate state.

Authors:  Brian C Mackness; Meme T Tran; Shannan P McClain; C Robert Matthews; Jill A Zitzewitz
Journal:  J Biol Chem       Date:  2014-02-04       Impact factor: 5.157

10.  Conformational switch upon phosphorylation: human CDK inhibitor p19INK4d between the native and partially folded state.

Authors:  Christian Löw; Nadine Homeyer; Ulrich Weininger; Heinrich Sticht; Jochen Balbach
Journal:  ACS Chem Biol       Date:  2009-01-16       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.